This protein from tardigrades may hold the key to protecting healthy tissues during cancer radiation treatment.
Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...
Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...
More than 2.7 million confirmed national cases of Covid-19 have been logged since our very first was announced on February 28 ...
Discover Viatris Inc.'s Q4 2024 earnings insights: from robust pipeline advancements to challenges like the Indore facility issues.
2h
Axios Vitals on MSNFunding for Moderna bird flu vaccine under reviewThe Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...
IPA's strategy melds AI-driven analytics with specialised wet-lab methodologies to design and optimise antibodies.
The Department of Health and Human Services is re-evaluating a $590 million contract for avian influenza mRNA vaccines that ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Robert F Kennedy Jr has issued a 90-day pause for a $200million Biden-era contract with Vaxart Inc to develop a new oral ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...
A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results